Page last updated: 2024-08-21

2-piperidone and Insulin Resistance

2-piperidone has been researched along with Insulin Resistance in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baik, SH; Choi, DS; Choi, KM; Hong, HC; Hwang, HJ; Jung, TW; Kim, BH; Kim, NH; Kim, SG; Seo, JA; Yoo, HJ	1
Ahn, CH; Cho, YM; Kim, EK; Min, SH; Oh, TJ	1
Choi, SH; Lee, CK; Lee, IK; Leem, J; Park, KG; Park, S	1

Trials

1 trial(s) available for 2-piperidone and Insulin Resistance

Article	Year
Effects of gemigliptin, a dipeptidyl peptidase-4 inhibitor, on lipid metabolism and endotoxemia after a high-fat meal in patients with type 2 diabetes. Diabetes, obesity & metabolism, 2017, Volume: 19, Issue:3 Topics: Adiponectin; Adult; Aged; Apolipoprotein B-100; Apolipoprotein B-48; Blood Glucose; C-Reactive Protein; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Cytokines; Diabetes Mellitus, Type 2; Diet, High-Fat; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Endotoxemia; Endotoxins; Female; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Insulin Resistance; Interleukin-6; Lipid Metabolism; Male; Middle Aged; Piperidones; Postprandial Period; Pyrimidines; RNA, Messenger; Subcutaneous Fat, Abdominal; Transcriptome; Triglycerides; Tumor Necrosis Factor-alpha	2017

Article

Year

Effects of gemigliptin, a dipeptidyl peptidase-4 inhibitor, on lipid metabolism and endotoxemia after a high-fat meal in patients with type 2 diabetes.

Diabetes, obesity & metabolism, 2017, Volume: 19, Issue:3

Topics: Adiponectin; Adult; Aged; Apolipoprotein B-100; Apolipoprotein B-48; Blood Glucose; C-Reactive Protein; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Cytokines; Diabetes Mellitus, Type 2; Diet, High-Fat; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Endotoxemia; Endotoxins; Female; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Insulin Resistance; Interleukin-6; Lipid Metabolism; Male; Middle Aged; Piperidones; Postprandial Period; Pyrimidines; RNA, Messenger; Subcutaneous Fat, Abdominal; Transcriptome; Triglycerides; Tumor Necrosis Factor-alpha

2017

Other Studies

2 other study(ies) available for 2-piperidone and Insulin Resistance

Article	Year
A dipeptidyl peptidase-IV inhibitor improves hepatic steatosis and insulin resistance by AMPK-dependent and JNK-dependent inhibition of LECT2 expression. Biochemical pharmacology, 2015, Nov-01, Volume: 98, Issue:1 Topics: AMP-Activated Protein Kinases; Animals; Dietary Fats; Dipeptidyl-Peptidase IV Inhibitors; Fatty Liver; Hep G2 Cells; Humans; Insulin Resistance; Intercellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; Mice; Mice, Inbred C57BL; Piperidones; Pyrimidines	2015
Gemigliptin ameliorates Western-diet-induced metabolic syndrome in mice. Canadian journal of physiology and pharmacology, 2017, Volume: 95, Issue:2 Topics: Adipocytes; Animals; Diet, Western; Fatty Liver; Fibrosis; Hypercholesterolemia; Hypertrophy; Inflammation; Insulin Resistance; Liver; Male; Metabolic Syndrome; Mice; Piperidones; Pyrimidines; Subcutaneous Fat; Uncoupling Protein 1; Weight Gain	2017

Article

Year

A dipeptidyl peptidase-IV inhibitor improves hepatic steatosis and insulin resistance by AMPK-dependent and JNK-dependent inhibition of LECT2 expression.

Biochemical pharmacology, 2015, Nov-01, Volume: 98, Issue:1

Topics: AMP-Activated Protein Kinases; Animals; Dietary Fats; Dipeptidyl-Peptidase IV Inhibitors; Fatty Liver; Hep G2 Cells; Humans; Insulin Resistance; Intercellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; Mice; Mice, Inbred C57BL; Piperidones; Pyrimidines

2015

Gemigliptin ameliorates Western-diet-induced metabolic syndrome in mice.

Canadian journal of physiology and pharmacology, 2017, Volume: 95, Issue:2

Topics: Adipocytes; Animals; Diet, Western; Fatty Liver; Fibrosis; Hypercholesterolemia; Hypertrophy; Inflammation; Insulin Resistance; Liver; Male; Metabolic Syndrome; Mice; Piperidones; Pyrimidines; Subcutaneous Fat; Uncoupling Protein 1; Weight Gain

2017